On the contrary, if your patient is young, large, and doesnt have any drug interactions, you may consider starting with 7.5 mg instead of 5 mg
On July 22, 2025, Viatris won a major legal victory in its patent litigation dispute, potentially accelerating the entry of a biosimilar or generic version of Wegovy before 2032
Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity
"The OAC applauds Lilly for another step forward in improving the affordability of obesity treatment," said Joe Nadglowski, president and CEO of the Self-pay patients with obesity now have additional Zepbound vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses
By Healthogenics